Association of high sensitivity C-Reactive Protein [hsCRP] and Tumour Necrosis Factor-α [TNF-α] with carotid Intimal Medial Thickness in subjects with different grades of glucose intolerance-The Chennai Urban Rural Epidemiology Study (CURES-31)

Clinical Biochemistry

Volumn 41, Issue 7-8, 2008, Pages 480-485

  Gokulakrishnan, Kuppan ^a   Deepa, Raj ^a   Mohan, Viswanathan ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

Asian Indians; Diabetes; Glucose intolerance; hsCRP; Intimal medial thickness; South Asians; TNF

Indexed keywords

C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; CAROTID ARTERY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE INTOLERANCE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INDIA; MALE; MIDDLE AGED; RURAL POPULATION; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA; URBAN POPULATION;

EID: 41949130341     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.01.030     Document Type: Article

References (41)

1. Stamler J., Vaccaro O., Neaton J.D., and Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434-444
2. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
3. Mohan V., Shanthirani C.S., and Deepa R. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and life style factors-The Chennai Urban Population Study (CUPS 14). J Assoc Physicians India 51 (2003) 771-777
4. Reddy K.S., and Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97 (1998) 596-601
5. Enas E.A., Garg A., Davidson M.A., et al. Coronary heart disease and its risk factors in first-generation immigrant Asian Indians to the United States of America. Indian Heart J 48 (1996) 343-353.
6. Mohan V., Deepa R., Rani S.S., and Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India-The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 38 (2001) 682-7.-850
7. Reaven G.M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 44 (1993) 121-131
8. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
9. Mendall M.A., Patel P., Asante M., et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78 (1997) 273-277
10. Lagrand W.K., Visser C.A., Hermens W.T., et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?. Circulation 100 (1999) 96-102
11. Ridker P.M., Rifai N., Pfeffer M.A., et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 98 (1998) 839-844
12. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., and Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349 (1997) 462-466
13. Biasucci L.M., Liuzzo G., Grillo R.L., et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99 (1999) 855-860
14. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAs). Circulation 102 (2000) 42-47
15. Mohan V., Deepa R., Velmurugan K., and Premalatha G. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6). Diabet Med 22 (2005) 863-870
16. Hotamisligil G.S., Budavari A., Murray D., and Spiegelman B.M. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest 94 (1994) 1543-1549
17. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 (2003) 2317-2322
18. Magyar M.T., Szikszai Z., Balla J., et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 34 (2003) 58-63
19. Matsuda M., Kawasaki F., Yamada K., et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects. Diabet Med 21 (2004) 881-888
20. Mohan V., Gokulakrishnan K., Sandeep S., Srivastava B.K., Ravikumar R., and Deepa R. Intimal media thickness, glucose intolerance and metabolic syndrome in Asian Indians-the Chennai Urban Rural Epidemiology Study (CURES-22). Diabet Med 23 (2006) 845-850
21. Deepa R., Arvind K., and Mohan V. Diabetes and risk factors for coronary artery disease. Curr Sci 83 (2002) 1497-1505
22. Deepa R., Velmurugan K., Arvind K., et al. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance-the Chennai Urban Rural Epidemiology Study (CURES). Metabolism 55 (2006) 1232-1238
23. Gokulakrishnan K., Deepa R., Mohan V., and Gross M.D. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome-the Chennai Urban Rural Epidemiology Study. Metabolism. 55 (2006) 237-242
24. Deepa M., Pradeepa R., Rema M., et al. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I). J Assoc Physicians India 51 (2003) 863-870
25. Rema M., Mohan V., Deepa R., and Ravikumar R. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy: the Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 27 (2004) 1962-1967
26. Report of the Expert Committee on the Diagnosis and Classification of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
27. Alberti K.G., and Zimmet P.Z. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet Med 15 (1998) 539-553
28. Mohan V., Ravikumar R., Shanthi Rani S., and Deepa R. Intimal medial thickness of the carotid artery in south Indian diabetic and nondiabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 43 (2000) 494-499
29. Ravikumar R., Deepa R., Shanthirani C.S., and Mohan V. Comparison of carotid intima-media thickness, arterial stiffness and brachial artery flow medicated dilatation in diabetic and non-diabetic subjects. (The Chennai Urban Population Study [CUPS NO:9]. Am J Cardiol 90 (2002) 702-707
30. Lonn E., Yusuf S., Dzavik V., et al. SECURE Investigators. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103 (2001) 919-925
31. Swahn E., von Schenck H., and Wallentin L. Plasma fibrinogen in unstable coronary artery disease. Scand J Clin Lab Invest 49 (1989) 49-54
32. Chambers J.C., Obeid O.A., Refsum H., et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet 355 (2000) 523-527
33. Chambers J.C., Eda S., Bassett P., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 104 (2001) 145-150
34. Bjornholt J.V., Erikssen G., Aaser E., et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care 22 (1999) 45-49
35. Piche M.E., Lemieux S., Weisnagel S.J., Corneau L., Nadeau A., and Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride levels in healthy postmenopausal women. Am J Cardiol. 96 (2005) 92-97
36. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
37. Gokulakrishnan K., Deepa R., Velmurugan K., Ravikumar R., Karkuzhali K., and Mohan V. Oxidized low-density lipoprotein and intimal medial thickness in subjects with glucose intolerance: the Chennai Urban Rural Epidemiology Study-25. Metabolism 56 (2007) 245-250
38. Aronson D., Bartha P., Zinder O., et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med 21 (2004) 39-44
39. Rajavashisth T.B., Xu X.P., Jovinge S., et al. Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators. Circulation 99 (1999) 3103-3109
40. Yeh T.H., Anderson V., Pasceri V., et al. C-reactive protein: linking inflammation to cardiovascular complications. Circulation 104 (2001) 974-975
41. Musial J., Undas A., Gajewski P., Jankowski M., Sydor W., and Szczeklik A. Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol 77 (2001) 247-253